Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New urine test could spare bladder cancer patients from failed treatments

NCT ID NCT04564781

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times

Summary

This study is testing a new urine test that aims to predict whether bladder cancer patients will respond well to a standard treatment called BCG. About 400 adults with intermediate or high-risk non-muscle invasive bladder cancer will provide urine samples before starting BCG therapy. The goal is to see if the test can accurately identify who will benefit, helping avoid unnecessary treatments or surgery for those who won't.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kyoto University

    RECRUITING

    Kyoto, Kyoto, 606-8501, Japan

    Contact

  • UCLA

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

  • UCSF

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

  • University of Texas Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.